Abstract
Context: There is mounting evidence suggesting bidirectional crosstalk between microbiota and host. However, the effects of probiotics on renal function and uremic toxins in chronic kidney disease (CKD) patients are unclear. Evidence Acquisitions: A literature review was conducted using MEDLINE, EMBASE, and Cochrane Database of Systematic Reviews from inception through November 2017 to identify randomized controlled trials (RCTs) assessing the effects of probiotics on renal function and uremic toxins in CKD patients. Effect estimates from the individual studies were extracted and combined using fixed-effect meta-analysis with inverse variance weights. Results: Five RCTs with 161 CKD patients were enrolled. Compared to controls, there were no significant differences in serum creatinine and estimated glomerular filtration rate (eGFR) after post-probiotic course (4 weeks to 6 months) with standardized mean differences (SMDs) of 0.01 (95% CI -0.29 to 0.30) and -0.01 (95% CI -0.43 to 0.41), respectively. Compared to the controls, p-cresol levels were significantly reduced after treatment with probiotics with SMD of -0.61 (95% CI -1.04 to -0.19). No significant infectious complications were noted during treatment with probiotics in CKD patients. Conclusions: Based on the findings of our meta-analysis, there are no significant changes in serum creatinine or eGFR after short-term treatment with probiotics, when compared to controls. However, our meta-analysis suggests potential beneficial effects of probiotics on uremic toxins in CKD patients. Future studies are required to assess its long-term effects on CKD progression and uremic toxins.
Highlights
Despite advancements in medicine, chronic kidney disease (CKD) remains a major public health issue [1,2] affecting as many as 10% to 15% of the adult population worldwide [3,4,5,6,7,8]
In this systematic review and meta-analysis consisting of five randomized controlled trials (RCTs) with 161 CKD patients, we demonstrate no significant changes in creatinine and estimated glomerular filtration rate (eGFR) after short-term treatment with probiotics when compared to controls
Effects of probiotics on renal function in CKD patients Study populations consisted of patients with CKD 3 to 5
Summary
Chronic kidney disease (CKD) remains a major public health issue [1,2] affecting as many as 10% to 15% of the adult population worldwide [3,4,5,6,7,8]. Studies have demonstrated associations of CKD with increased risks of cardiovascular disease, significant comorbidities, increased health care costs, reduced quality of life, and increased mortality [2, 9]. Literature review and search strategy C.T. and W.C individually searched published studies and conference abstracts indexed in EMBASE, MEDLINE, and the Cochrane database from inception through November 2017 using the following words: “prebiotics”, “synbiotics” or “probiotic” AND “renal” or “chronic kidney disease”, or “kidney” (Supplementary file 1).
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
